A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study

Table 3

Summary list of serious adverse events and nonserious adverse events.

Serious adverse events	(%)
Primary system organ class; Preferred term [ (%)]
Any class	1 (0.37%)
Cardiac disorders	1 (0.37%)
Bradycardia	1 (0.37%)
Nervous system disorders	1 (0.37%)
Presyncope	1 (0.37%)
Nonserious adverse events
Primary system organ class; Preferred term [ (%)]
Any class	4 (1.48%)
Respiratory, thoracic, and mediastinal disorders	4 (1.48%)
Cough	4 (1.48%)
Infections and infestations	1 (0.37%)
Pharyngitis	1 (0.37%)

AE: adverse event; SOC: system organ class, PT: preferred term MedDRA 20.0; ; .